Hospital Based Registry of Childhood Cancer in Pediatric Oncology Units in French Speaking Africa
Launched by FRENCH AFRICA PEDIATRIC ONCOLOGY GROUP · Jan 14, 2019
Trial Information
Current as of October 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding childhood cancer in French-speaking countries in Africa. It aims to collect important information about children who come to oncology units for treatment. By gathering details on the types of cancer, how advanced they are when diagnosed, the treatments given, and the results of those treatments, the researchers hope to improve the care and planning for pediatric cancer programs in the region.
If your child is under 18 and has been diagnosed with any type of cancer, they may be eligible to participate in this study. The researchers are currently recruiting participants, so families can expect to share information about their child's condition and treatment. This data will be vital for local and national health authorities to better support and improve services for children with cancer in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Any child presenting at any one of the participating units for treatment
- • 2. Any child with any type of cancer
- • 3. Any child or adolescent less than 18 years of age.
- Exclusion Criteria:
- • 1. No cancer found
- • 2. Age greater than 18 years -
About French Africa Pediatric Oncology Group
The French Africa Pediatric Oncology Group (FAPOG) is a collaborative network dedicated to improving outcomes for children with cancer in Africa. Comprising a multidisciplinary team of healthcare professionals, researchers, and advocates, FAPOG aims to enhance clinical practices, promote research initiatives, and foster capacity building within pediatric oncology. Through innovative clinical trials and partnerships with local institutions, FAPOG seeks to address the unique challenges faced by pediatric cancer patients in African contexts, ensuring equitable access to effective treatments and improving survival rates across the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ouagadougou, Burkina Faso
Ouagadougou, Burkina Faso
Yaoundé, Cameroon
Kinshasa, Congo, The Democratic Republic Of The
Lubumbashi, Congo, The Democratic Republic Of The
Abidjan, Côte D'ivoire
Villejuif, Paris, France
Libreville, Gabon
Antananarivo, Ampefiloha, Madagascar
Bamako, Mali
Nouakchott, Mauritania
Niamey, Niger
Dakar, Senegal
Lomé, Togo
Patients applied
Trial Officials
Brenda Mallon, MSc
Study Director
French Africa Pediatric Oncology Group
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials